{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:00:26Z","timestamp":1784959226005,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04933-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:53:54Z","timestamp":1779490434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic model for patients with hepatoid adenocarcinoma of the stomach"],"prefix":"10.1186","volume":"26","author":[{"given":"Shan","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"9","key":"4933_CR1","doi-asserted-by":"publisher","first-page":"e030639","DOI":"10.1136\/bmjopen-2019-030639","volume":"9","author":"K Hu","year":"2019","unstructured":"Hu K, Wang S, Wang Z, Li L, Huang Z, Yu W, Chen Z, Wu QF. Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China. BMJ Open. 2019;9(9):e030639.","journal-title":"BMJ Open"},{"key":"4933_CR2","doi-asserted-by":"publisher","first-page":"l5016","DOI":"10.1136\/bmj.l5016","volume":"366","author":"WQ Li","year":"2019","unstructured":"Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, Guo Y, Zhou T, Li JY, Shen L, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019;366:l5016.","journal-title":"BMJ"},{"issue":"3","key":"4933_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/mc.23851","volume":"64","author":"Y Yu","year":"2025","unstructured":"Yu Y, Zheng Z, Gao X, Gu Y, Zhang M, Hu B, Gao Q, Li Z, Chen Y, Li Q, et al. Plasma Metabolomic Signatures of H. pylori Infection, Alcohol Drinking, Smoking, and Risk of Gastric Cancer. Mol Carcinog. 2025;64(3):463\u201374.","journal-title":"Mol Carcinog"},{"key":"4933_CR4","doi-asserted-by":"publisher","first-page":"1333623","DOI":"10.3389\/fonc.2024.1333623","volume":"14","author":"K Pu","year":"2024","unstructured":"Pu K, Feng Y, Tang Q, Yang G, Xu C. Review of dietary patterns and gastric cancer risk: epidemiology and biological evidence. Front Oncol. 2024;14:1333623.","journal-title":"Front Oncol"},{"key":"4933_CR5","doi-asserted-by":"publisher","unstructured":"Lim JH, Shin CM, Han K, Jung JH, Choi J, Jin EH, Kang SJ, Lee DH. Smoking, Alcohol, and Abdominal Obesity Increase Gastric Cancer Risk after Helicobacter pylori Eradication. Cancer Res Treat. 2026. https:\/\/doi.org\/10.4143\/crt.2025.1200.","DOI":"10.4143\/crt.2025.1200"},{"issue":"6","key":"4933_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/ijc.33678","volume":"149","author":"G Collatuzzo","year":"2021","unstructured":"Collatuzzo G, Pelucchi C, Negri E, Lopez-Carrillo L, Tsugane S, Hidaka A, Shigueaki Hamada G, Hernandez-Ramirez RU, Lopez-Cervantes M, Malekzadeh R, et al. Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: A pooled analysis in the Stomach cancer Pooling (StoP) Project. Int J Cancer. 2021;149(6):1228\u201338.","journal-title":"Int J Cancer"},{"issue":"1","key":"4933_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cncr.34511","volume":"129","author":"Y Li","year":"2023","unstructured":"Li Y, Ren N, Zhang B, Yang C, Li A, Li X, Lei Z, Fei L, Fan S, Zhang J. Gastric cancer incidence trends in China and Japan from 1990 to 2019: Disentangling age-period-cohort patterns. Cancer. 2023;129(1):98\u2013106.","journal-title":"Cancer"},{"issue":"1","key":"4933_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-025-01698-y","volume":"18","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia K, Xie Y, Yuan J, Liu D, Jiang L, Peng H, Zhong J, Li J, Zhang X, et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J Hematol Oncol. 2025;18(1):42.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"4933_CR9","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1097\/JS9.0000000000002464","volume":"111","author":"P Yang","year":"2025","unstructured":"Yang P, Huang W, Xu Y, Teng Y, Shu P. Trends and projections of the burden of gastric cancer in China and G20 countries: a comparative study based on the global burden of disease database 2021. Int J Surg. 2025;111(7):4854\u201365.","journal-title":"Int J Surg"},{"issue":"1","key":"4933_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/1097-0142(19860701)58:1<119::AID-CNCR2820580121>3.0.CO;2-U","volume":"58","author":"H Ishikura","year":"1986","unstructured":"Ishikura H, Kirimoto K, Shamoto M, Miyamoto Y, Yamagiwa H, Itoh T, Aizawa M. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer. 1986;58(1):119\u201326.","journal-title":"Cancer"},{"issue":"1","key":"4933_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/JS9.0000000000001768","volume":"111","author":"YQ Huang","year":"2025","unstructured":"Huang YQ, Huang ZN, Hong QQ, Zhang P, Zhang ZZ, He L, Shang L, Wang LJ, Sun YF, Li ZX, et al. Development of a staging system for hepatoid adenocarcinoma of the stomach based on multicenter data: a retrospective cohort study. Int J Surg. 2025;111(1):718\u201327.","journal-title":"Int J Surg"},{"issue":"6","key":"4933_CR12","first-page":"e2101","volume":"7","author":"S Yanagawa","year":"2024","unstructured":"Yanagawa S, Tanabe K, Kano M, Hotta R, Saeki Y, Fujikuni N, Ohdan H. Hiroshima Surgical Study Group of Clinical O: Clinicopathological features of hepatoid adenocarcinoma of the stomach: A multicenter retrospective study. Cancer Rep (Hoboken). 2024;7(6):e2101.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"10","key":"4933_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.14740\/jmc4263","volume":"15","author":"L Bathobakae","year":"2024","unstructured":"Bathobakae L, Elagami M, Mahmoud A, Kesrani J, Yuridullah R, Melki G, Akmal A, Cavanagh Y, Baddoura W. Alpha-Fetoprotein-Producing Hepatoid Adenocarcinoma of the Stomach. J Med Cases. 2024;15(10):304\u20139.","journal-title":"J Med Cases"},{"issue":"16","key":"4933_CR14","doi-asserted-by":"publisher","first-page":"e70130","DOI":"10.1002\/cam4.70130","volume":"13","author":"Q Ling","year":"2024","unstructured":"Ling Q, Liu HL, Huang ST, Sun LF, Wu WW, Kudriashov V, Liu K, Yang K, Hu JK, Zhang WH. Clinicopathological features of hepatoid adenocarcinoma and non-hepatoid adenocarcinoma of the stomach: A systematic review and meta-analysis. Cancer Med. 2024;13(16):e70130.","journal-title":"Cancer Med"},{"issue":"5","key":"4933_CR15","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.21037\/jgo-24-210","volume":"15","author":"X Gu","year":"2024","unstructured":"Gu X, Rong J, Zhu L, Dai Z, Ren S, Chen J, Yin B, Wang Z. Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram. J Gastrointest Oncol. 2024;15(5):2041\u201352.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"4933_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12885-020-07031-9","volume":"20","author":"K Zhou","year":"2020","unstructured":"Zhou K, Wang A, Ao S, Chen J, Ji K, He Q, Ji X, Wu X, Zhang J, Li Z, et al. The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer. 2020;20(1):671.","journal-title":"BMC Cancer"},{"issue":"1","key":"4933_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1186\/s12885-024-12873-8","volume":"24","author":"X Luan","year":"2024","unstructured":"Luan X, Zhao L, Zhang F, Wang W, Jiao F, Zhou X, Niu P, Han X, Zhang X, Zhao D, et al. Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China. BMC Cancer. 2024;24(1):1149.","journal-title":"BMC Cancer"},{"issue":"1","key":"4933_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2021.5104","volume":"157","author":"C Huang","year":"2022","unstructured":"Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, et al. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial. JAMA Surg. 2022;157(1):9\u201317.","journal-title":"JAMA Surg"},{"key":"4933_CR19","doi-asserted-by":"publisher","first-page":"716962","DOI":"10.3389\/fonc.2021.716962","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Li Y, Du X. Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study. Front Oncol. 2021;11:716962.","journal-title":"Front Oncol"},{"issue":"8","key":"4933_CR20","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.ejso.2017.04.005","volume":"43","author":"D Reim","year":"2017","unstructured":"Reim D, Choi YS, Yoon HM, Park B, Eom BW, Kook MC, Ryu KW, Choi IJ, Joo J, Kim YW. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection. Eur J Surg Oncol. 2017;43(8):1542\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"4933_CR21","doi-asserted-by":"publisher","first-page":"772636","DOI":"10.3389\/fonc.2021.772636","volume":"11","author":"WP Huang","year":"2021","unstructured":"Huang WP, Li LM, Li J, Yuan JH, Hou P, Liu CC, Ma YH, Liu XN, Han YJ, Liang P, et al. Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach. Front Oncol. 2021;11:772636.","journal-title":"Front Oncol"},{"issue":"10","key":"4933_CR22","doi-asserted-by":"publisher","first-page":"e2128217","DOI":"10.1001\/jamanetworkopen.2021.28217","volume":"4","author":"JX Lin","year":"2021","unstructured":"Lin JX, Wang ZK, Hong QQ, Zhang P, Zhang ZZ, He L, Wang Q, Shang L, Wang LJ, Sun YF, et al. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach. JAMA Netw Open. 2021;4(10):e2128217.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4933_CR23","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.62347\/DBFO6813","volume":"15","author":"ZY Xiang","year":"2025","unstructured":"Xiang ZY, Hu YY, Zheng Q, Yu WM, Liu XC, Chen P, Wu F, Pan JH, Ji SQ, Gu LH. Clinicopathological characteristics and prognostic outcomes of resectable hepatoid adenocarcinoma of the stomach: insights from a multicenter case-control study. Am J Cancer Res. 2025;15(4):1689\u2013704.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4933_CR24","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1002\/cjp2.343","volume":"10","author":"X Yang","year":"2024","unstructured":"Yang X, Wu Y, Wang A, Ma X, Zhou K, Ji K, Ji X, Zhang J, Wu X, Li Z, et al. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases. J Pathol Clin Res. 2024;10(1):e343.","journal-title":"J Pathol Clin Res"},{"key":"4933_CR25","doi-asserted-by":"publisher","first-page":"156089","DOI":"10.1016\/j.prp.2025.156089","volume":"272","author":"HF Ma","year":"2025","unstructured":"Ma HF, Li ZN, Li JQ, Wang M, Xiao WH, Shu P, Shi XH. Clinicopathological significance of identifying glypican 3 -positive gastric cancer. Pathol Res Pract. 2025;272:156089.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"4933_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","volume":"34","author":"T Ushiku","year":"2010","unstructured":"Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol. 2010;34(4):533\u201340.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4933_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12876-021-01986-0","volume":"21","author":"B Wang","year":"2021","unstructured":"Wang B, Xie Y, Zheng L, Zheng X, Gao J, Liu X, Yuan Y, Li Z, Lu N, Xue L. Both the serum AFP test and AFP\/GPC3\/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma. BMC Gastroenterol. 2021;21(1):408.","journal-title":"BMC Gastroenterol"},{"key":"4933_CR28","doi-asserted-by":"publisher","first-page":"126978","DOI":"10.1016\/j.jtemb.2022.126978","volume":"72","author":"MK Turkdogan","year":"2022","unstructured":"Turkdogan MK, Karapinar HS, Kilicel F. Serum trace element levels of gastrointestinal cancer patients in an endemic upper gastrointestinal cancer region. J Trace Elem Med Biol. 2022;72:126978.","journal-title":"J Trace Elem Med Biol"},{"key":"4933_CR29","doi-asserted-by":"publisher","unstructured":"Triantafillidis JK, Papakontantinou J, Antonakis P, Konstadoulakis MM, Papalois AE. Enteral Nutrition in Operated-On Gastric Cancer Patients: An Update. Nutrients. 2024;16(11):1639. https:\/\/doi.org\/10.3390\/nu16111639.","DOI":"10.3390\/nu16111639"},{"issue":"4","key":"4933_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10147-018-1274-7","volume":"23","author":"H Sawayama","year":"2018","unstructured":"Sawayama H, Iwatsuki M, Kuroda D, Toihata T, Uchihara T, Koga Y, Yagi T, Kiyozumi Y, Eto T, Hiyoshi Y, et al. Total iron-binding capacity is a novel prognostic marker after curative gastrectomy for gastric cancer. Int J Clin Oncol. 2018;23(4):671\u201380.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"4933_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1186\/s12885-023-11620-9","volume":"23","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li Y, Chen Z. Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer. BMC Cancer. 2023;23(1):1095.","journal-title":"BMC Cancer"},{"issue":"1","key":"4933_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/03936155251319784","volume":"40","author":"L Qin","year":"2025","unstructured":"Qin L, Liu F, Sun C, Zhang Z, Sun L, Tang X, Xia Y. Alcohol dehydrogenase iron containing 1 (ADHFE1) is associated with liver metastasis and regulates cellular function of gastric cancer. Int J Biol Markers. 2025;40(1):67\u201374.","journal-title":"Int J Biol Markers"},{"key":"4933_CR33","doi-asserted-by":"publisher","unstructured":"Collatuzzo G, Teglia F, Pelucchi C, Negri E, Rabkin CS, Liao LM, Sinha R, Lopez-Carrillo L, Lunet N, Morais S et al. Inverse Association between Dietary Iron Intake and Gastric Cancer: A Pooled Analysis of Case-Control Studies of the Stop Consortium. Nutrients. 2022;14(12):2555. https:\/\/doi.org\/10.3390\/nu14122555.","DOI":"10.3390\/nu14122555"},{"key":"4933_CR34","doi-asserted-by":"publisher","first-page":"111006","DOI":"10.1016\/j.clinbiochem.2025.111006","volume":"140","author":"V Susini","year":"2025","unstructured":"Susini V, Franzini M, Ursino S, Ghilardi M, Morganti R, Scatena C, Bianco I, Mazzoni A, Ghilli M. Circulating free PSA in breast cancer patients: is it a reliable biomarker? Clin Biochem. 2025;140:111006.","journal-title":"Clin Biochem"},{"issue":"5","key":"4933_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000041","volume":"10","author":"D Jiao","year":"2019","unstructured":"Jiao D, Li Y, Yang F, Han D, Wu J, Shi S, Tian F, Guo Z, Xi W, Li G, et al. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma. Clin Transl Gastroenterol. 2019;10(5):1\u20137.","journal-title":"Clin Transl Gastroenterol"},{"issue":"48","key":"4933_CR36","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.3748\/wjg.v26.i48.7664","volume":"26","author":"LX Chen","year":"2020","unstructured":"Chen LX, Zou SJ, Li D, Zhou JY, Cheng ZT, Zhao J, Zhu YL, Kuang D, Zhu XH. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World J Gastroenterol. 2020;26(48):7664\u201378.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4933_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.eururo.2015.04.028","volume":"69","author":"K Braun","year":"2016","unstructured":"Braun K, Sjoberg DD, Vickers AJ, Lilja H, Bjartell AS. A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort. Eur Urol. 2016;69(3):505\u201311.","journal-title":"Eur Urol"},{"key":"4933_CR38","doi-asserted-by":"publisher","first-page":"116156","DOI":"10.1016\/j.bmc.2021.116156","volume":"39","author":"A Bertokova","year":"2021","unstructured":"Bertokova A, Bertok T, Jane E, Hires M, Dubjakova P, Novotna O, Belan V, Fillo J, Tkac J. Detection of N,N-diacetyllactosamine (LacdiNAc) containing free prostate-specific antigen for early stage prostate cancer diagnostics and for identification of castration-resistant prostate cancer patients. Bioorg Med Chem. 2021;39:116156.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"4933_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/JU.0000000000000808","volume":"204","author":"DTS Woon","year":"2020","unstructured":"Woon DTS, Herrera-Caceres JO, Goldberg H, Shiakh H, Whelan E, Nason G, Ajib K, Tan GH, Chandrasekar T, Alhunaidi O, et al. A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens. J Urol. 2020;204(2):289\u201395.","journal-title":"J Urol"},{"issue":"2","key":"4933_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/bju.16751","volume":"136","author":"AW Silagy","year":"2025","unstructured":"Silagy AW, Woon DTS, Kostos L, Bernardino R, Yiu TW, Wettstein MS, Goldberg H, Herrera-Caceres JO, Shiakh H, Nason G, et al. Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer. BJU Int. 2025;136(2):329\u201335.","journal-title":"BJU Int"},{"issue":"5","key":"4933_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.canep.2013.06.009","volume":"37","author":"FC Mashkoor","year":"2013","unstructured":"Mashkoor FC, Al-Asadi JN, Al-Naama LM. Serum level of prostate-specific antigen (PSA) in women with breast cancer. Cancer Epidemiol. 2013;37(5):613\u20138.","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"4933_CR42","first-page":"1221","volume":"26","author":"C Chen","year":"2007","unstructured":"Chen C, Chen LQ, Yang GL, Li Y. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Ai Zheng. 2007;26(11):1221\u20136.","journal-title":"Ai Zheng"},{"issue":"94\u201395","key":"4933_CR43","first-page":"1388","volume":"56","author":"XQ Yang","year":"2009","unstructured":"Yang XQ, Yan L, Chen C, Hou JX, Li Y. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement. Hepatogastroenterology. 2009;56(94\u201395):1388\u201394.","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"4933_CR44","doi-asserted-by":"publisher","first-page":"e22565","DOI":"10.1002\/jcla.22565","volume":"32","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang Y, Sun L, Wang S, Nie J, Zhao W, Zheng G. Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer. J Clin Lab Anal. 2018;32(8):e22565.","journal-title":"J Clin Lab Anal"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04933-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:01:59Z","timestamp":1784955719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4933"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04933-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in strict accordance with the Declaration of Helsinki. Ethical approval for this study was waived by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University with an exemption from informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"466"}}